Scotia Capital Inc. Has $2.12 Million Stake in Colgate-Palmolive (CL)
Scotia Capital Inc. lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 3.7% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,562 shares of the company’s stock after acquiring an additional 1,016 shares during the period. Scotia Capital Inc.’s holdings in Colgate-Palmolive were worth $2,117,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. American Beacon Advisors Inc. purchased a new position in shares of Colgate-Palmolive during the 1st quarter worth $102,000. Proficio Capital Partners LLC raised its holdings in shares of Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after acquiring an additional 207 shares during the period. OLD Second National Bank of Aurora purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth $109,000. Hanson & Doremus Investment Management raised its holdings in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after acquiring an additional 70 shares during the period. Finally, Captrust Financial Advisors purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth $122,000. Institutional investors and hedge funds own 72.96% of the company’s stock.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the sale, the insider now owns 60,528 shares in the company, valued at $4,422,780.96. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $73.28, for a total value of $549,600.00. Following the completion of the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,673 shares of company stock valued at $12,629,293. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive (NYSE CL) opened at $73.20 on Friday. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27. The company has a market capitalization of $65,199.31, a PE ratio of 25.87, a PEG ratio of 3.40 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.73. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.73 earnings per share. research analysts predict that Colgate-Palmolive will post 2.88 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.
CL has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective on the stock in a report on Monday, September 25th. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Macquarie initiated coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price objective on the stock. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $75.00 to $84.00 in a report on Monday, September 25th. Finally, Jefferies Group reduced their price objective on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating on the stock in a report on Monday, October 30th. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the stock. Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $76.04.
TRADEMARK VIOLATION NOTICE: This article was originally published by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was copied illegally and republished in violation of international trademark & copyright legislation. The original version of this article can be accessed at https://www.dailypolitical.com/2017/12/08/scotia-capital-inc-has-2-12-million-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.